Menu

Top Stories

Kamada Submits Proposed Phase 3 Protocol to FDA for Inhaled Alpha-1 Antitrypsin Treatment

Kamada Submits Proposed Phase 3 Protocol to FDA for Inhaled Alpha-1 Antitrypsin Treatment
Friday, July 21, 2017
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, today announced that the Company has submitted to the U.S. Food and Drug Administration (FDA) for review a proposed pivotal Phase 3 protocol for its proprietary inhaled Alpha–1 Antitrypsin (AAT) therapy (Inhaled AAT) for the treatment of Alpha–1 Antitrypsin Deficiency (AATD). The proposed...
Divider

Nicotine addict finds hope after Alpha-1 Antitrypsin Deficiency diagnosis

Wednesday, July 19, 2017
Diagnosed with the lungs of a 126-year-old man from years of smoking and a rare genetic lung disorder, Ryan Taylor moved home from Alberta this past Christmas to die. But a news report his father saw on Memorial’s School of...
Divider

5-year old Alpha becomes the face of Australia’s DonateLife Week

Monday, July 17, 2017
If you still aren't sure about whether or not to become an organ donor, look into the eyes of Archer Irwin. The five-year-old from Wodonga has become the face of DonateLife Week, the federal government's push to have more...
Divider

Alpha Emma Lou Carr Glenn passes away

Monday, July 17, 2017
Emma Louise (Lou) Glenn passed away Tuesday, July 11. Many in the Alpha-1 community will remember Lou as Patti Brown's mom.  Patti is an AlphaNet Coordinator in Texas.  Lou became involved in the Alpha-1 community after Patti's...
Divider

Foundation president and CEO urges Alphas to find their place in the Alpha-1 Community

Thursday, June 29, 2017
CHICAGO, Illinois – Henry Moehring, president and CEO of the Alpha–1 Foundation, presided over the 26th and largest National Education Conference of the Alpha–1 community since its inception, he said in his Foundation update...
Divider

Alpha-1 Foundation Accepting Proposals for the John W. Walsh Translational Research Award in Alpha-1 Antitrypsin Deficiency

Wednesday, June 28, 2017
The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha-1 worldwide. This award is named after John W. Walsh, who dedicated his life’s work to finding...
Divider

Barbara Pusey honored in memoriam at Alpha–1 awards and recognition night

Monday, June 26, 2017
Barbara Pusey, who was the first AlphaNet Coordinator for the augmentation therapy marketed in the United States as Zemaira and was a major influence in building the AlphaNet Zemaira program into what it is today, was recognized posthumously, with...
Divider

Grifols announces $1 million grant to support Alpha-1 Foundation’s John W. Walsh Research Fund

Monday, June 26, 2017
Washington, DC  — Grifols announced that it will award a million-dollar grant to support the John. W. Walsh Research Fund, the Foundation’s peer-reviewed research program named in honor of Walsh, the Foundation’s co-founder...
Divider

Alpha-1, the "genetic component" in COPD, featured in national news magazine

Thursday, June 8, 2017
The following article on Alpha-1 Antitrypsin Deficiency is from U.S. News Health. It contains extensive quotes from Robert Sandhaus, MD, PhD, clinical director of the Alpha-1 Foundation and medical director of AlphaNet. You might not realize...
Divider

More Than 600 to Hear Top World Experts on Alpha-1 at National Conference in Chicago

Monday, June 5, 2017
CHICAGO, June 5, 2017 – More than 600 people with Alpha–1 Antitrypsin Deficiency – the most common known genetic cause of chronic obstructive pulmonary disease (COPD) – along with their family members, caregivers and...
Divider

International Research Conference explores novel treatments for Alpha-1, other health conditions

Monday, June 5, 2017
Professor Professor Noel G. "Gerry" McElvaney was delighted with the 3rd International Research Conference on Alpha-1 Antitrypsin Deficiency held in Lisbon, Portugal April 5-6. Professor McElvaney addresses the conference. "We...
Divider

Alpha-1 Foundation earns 7th consecutive 4-star rating from Charity Navigator

Friday, June 2, 2017
The Alpha-1 Foundation has earned its seventh consecutive 4-star rating from Charity Navigator. "Only 3% of the charities we evaluate have received at least 7 consecutive 4-star evaluations, indicating that the Alpha-1 Foundation...
Divider

Famed sportswriter Frank Deford passes at 78

Monday, May 29, 2017
Frank Deford, a famed sportswriter for more than half a century, a weekly commentator for National Public Radio's Morning Edition for 37 years, and who was elected U.S. Sportswriter of the Year six times for his work with Sports...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive